Healthcare Industry News: KGaA
News Release - March 1, 2010
Merck KGaA and Millipore Announce Transaction - Video Interview with Merck CEO
LONDON, March 1, 2010 (Healthcare Sales & Marketing Network) -- Merck, the global pharmaceutical and chemical company, announced it is to acquire all outstanding shares of Millipore, the US life sciences company, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately EUR 5.3 billion (US$ 7.2 billion), creating a world-class partner for the life science sector.In a video interview on broadcaster http://www.cantos.com, Dr Karl-Ludwig Klay, Merck Chief Executive, said the transaction was "truly transformational" for Merck's Chemicals business.
"We believe that the acquisition is very compelling and fully in line with our strategy."
The interview and transcript are available now on http://www.cantos.com/company/merck.
Cantos.com, the online financial broadcaster, features in-depth interviews, documentaries and webcasts with senior company executives. If you would like to contact us, please email amanda.alexander@cantos.com or phone +44-207-936-1352.
Source: Merck KGaA
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!